Drug Shortage Report for APO-OXYCODONE CR
Report ID | 151889 |
Drug Identification Number | 02366754 |
Brand name | APO-OXYCODONE CR |
Common or Proper name | OXYCODONE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | OXYCODONE HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 BTL |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-12-20 |
Estimated end date | 2022-03-18 |
Actual end date | 2022-03-18 |
Shortage status | Resolved |
Updated date | 2022-03-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-03-21 | French | Compare |
v5 | 2022-03-21 | English | Compare |
v4 | 2022-03-09 | French | Compare |
v3 | 2022-03-09 | English | Compare |
v2 | 2021-12-24 | French | Compare |
v1 | 2021-12-24 | English | Compare |
Showing 1 to 6 of 6